9th Annual Medical Communications and Dissemination of Scientific Information Conference

September 14-16, 2020 | Virtual Event

DAY ONE | MONDAY, APRIL 6

8:00 REGISTRATION & WELCOME COFFEE

8:50 CHAIRPERSON’S OPENING REMARKS

9:00 DEVELOPMENT OF PLAIN LANGUAGE SUMMARIES FOR INCREASED HEALTH LITERACY
As initiatives to increase data transparency and further improve patient focused communication continues to spread throughout the life science industry, the focus has shifted to the language and delivery method of medical data that is being distributed. Manufacturers are a primary source of product data and rather than relying solely on patient’s garnering needed information from advocacy groups and HCPS, medical communication and publication leads are exploring avenues to transition typically dense medical data into more easily understandable documents for patients and caregivers. It is critical for executives to understand how to best transition information pieces from a clinician and HCP focused to more patient-friendly messaging without diluting the scientifically based foundation.

Angela Sykes, Director, Team Leader, Publications Management Team, PFIZER

 

9:45 INTERCONNECTIVITY AND INTERNAL COLLABORATION BETWEEN MEDICAL AFFAIRS AND PRODUCT TEAMS

  • Evolution of medical communication and publication teams
  • Involvement of medical affairs leaders in the product strategy
  • Collaboration with medical and field based personnel
  • Siloed vs. integrated med comm and publications teams

Nathan Thibault, Director, Global Scientific Communications, SANOFI

 

10:30 COFFEE AND NETWORKING BREAK

 

11:00 PANEL: EVOLUTION OF SCIENTIFIC PLATFORMS THROUGHOUT THE PRODUCT LIFECYCLE

  • Exploring ideal timeline to begin platform development
  • Best practices in formatting of scientific platforms
  • Pre-clinical vs. clinical material creation within lexicons
  • Expansion of scientific platform for products post market

Scott Baver, RHYTHM PHARMACEUTICALS

Iwona Bucior, MYOKARDIA

Olivier Morteau, ALEXION PHARMACEUTICALS

 

11:45 LEGAL PERSPECTIVE: COMPLIANCE CONSIDERATIONS IMPACTING PATIENT OUTREACH STRATEGIES
As the focus on patient centricity continues to expand into all areas of a product’s lifecycle, manufacturers continue to explore how to realistically engage this initiative in order to ensure desired outcomes are reached. Medical communication teams face an added layer of complexity with patient focused communications due to the highly regulated nature of the industry in regards to patient specific communications. In order to proactively engage in strong patient outreach strategies, medical communication leaders must be aware of the compliance considerations when developing patient directed content and visuals to circumvent crossing into any areas of non-compliance.

Monica Chmielewski, Partner, FOLEY AND LARDNER

 

12:30 LUNCHEON FOR ALL SPEAKERS, SPONSORS & ATTENDEES

 

1:30 PANEL DISCUSSION: BUILDING A MEDICAL COMMUNICATION OUTREACH PLAN FOR NEW PRODUCTS

  • Creation of the initial product communication strategy roadmap
  • Determination of timeline for medical affairs team involvement
  • Establishing materials needed to support commercial product plans
  • Conceptualizing and preparing product profile information

Jodie Gillon, ABEONA THERAPEUTICS

Leah Eardley, VERTEX PHARMACEUTICALS

Alan Polnariev, FERRING PHARMACEUTICALS

Efy Leonardi, PTC THERAPEUTICS

 

MODULE: DIGITAL CAPABILITIES FOR PUBLICATION & MEDICAL COMMUNICATION MESSAGING
Continued technological advancements are offering life science corporations of all sizes various avenues for increasing the reach of medical and scientific communication, allowing for greater targeting, customization and organizational efficiency in content development. While the integration of technology can enable companies to increase prominence and visibility within a competitive market, the heavily regulated nature of the life science industry requires medical communication teams to thoroughly vet the most appropriate applications. Through a two-part module, executives will explore legal and compliance considerations when looking to launch into new digital information outreach such as navigating unsolicited vs. solicited information requests and ensuring information dissemination does not traverse into a marketing strategy.

 

2:15 CASE STUDY: HIGHLIGHTING COMPLIANCE PARAMETERS SURROUNDING USE OF DIGITAL PLATFORMS

Lee Rosebush, Partner, BAKER & HOSTELTER LLP

 

3:00 COFFEE AND NETWORKING BREAK

 

3:30 PANEL DISCUSSION: SEAMLESS INTEGRATION OF DIGITAL CAPABILITIES INTO MEDICAL COMMUNICATION PROJECTS

Lee Rosebush, BAKER & HOSTELTER LLP

Joanna Rega, RADIUS HEALTH

Kimberly Della Penna, MERCK

 

4:15 SMALL GROUP DISCUSSIONS: MEDICAL COMMUNICATION CHALLENGES BASED ON PRODUCT LIFECYCLE PHASE
Medical communication plans encompass the development of a variety of different data messages that will be disseminated through a product’s entire lifecycle and depending on the current phase of development for product the challenges and responsibilities of the medical communication teams can vary ranging from clinical engagement, publishing operations through to scientific content development. Through facilitated small group discussion, attendees will be able to directly address operational process associated with specific phases of a product’s lifecycle.

GROUP ONE: CLINICAL/PRE-LAUNCH
Debra Sutkowski, ASTELLAS PHARMA, INC.

GROUP TWO: PRODUCT LAUNCH
Rod Gedey, ARENA PHARMACEUTICALS

 

5:00 END OF DAY ONE CONFERENCE